Studies have proven that CD8+ T cells in favorable acute myeloid leukemia (AML) facilitated the growth of leukemia stem/progenitor cells (LSPCs) by way of stimulating the autocrine manufacturing of necessary hematopoietic cytokines such as interleukin-3 (IL-3). Here, IL3 is linked to leukemia.